JOINT BIOLOGICAL WARFARE DEFENSE COMMITTEE TANK BRIEF

File: 123096_sep96_decls63_0004.txt
Page: 0004
Total Pages: 15

Subject: JOINT BIOLOGICAL WARFARE DEFENSE COMMITTEE TANK BRIEF           

Unit: OTSG        

Parent Organization: HSC         

Box  ID: BX003203

Folder Title: JOINT BIO WARFARE DEFENSE COMMITTEE TANK BRIEF                                                  

Document Number:          1

Folder Seq  #:        248


                                          U N C LA$-S.IF-[E D


                                    DEPARTMENT OF THE ARMY
                                    OFFICE OF THE SURGEON GENERAL
                                         5109 LEESSUFIG PIKE
                                      FALLS CHURCH, VA 22041-3258
                  REPLY TO
                  ATTENTION QF

            SGPS-ZA (50)


            MEMORANDUM FOR OFFICE OF THE DEPUTY CHIEF OF STAFF FOR
                               OPERATIONS AND PLANS, WASHINGTON, DC       20310

            SUBJECT: Vaccine Policy Recommendation


            1. (U) Reference: Memorandum, HQDA (ODCSOPS), DAMO-SW,
            9 September 1991, Subject: minutes of the Biological Defense
            Committee Meeting, 29 August 1991, Memorandum 3-91. (U)

            2. (U) This memorandum provides information for ODCSOPS and
            the Biological Defense Committee to make a vaccine policy
            recommendation.


            3.        The facts are:

                  a.        In FY92, the United States can only vaccinate
                     Service Members (SM) against anthrax and               against
             otuilnum.

                  b.        In FY93, an additional             sm can be vaccinated
            against anthrax. The level of production of        botulinum toxoid in
            FY93 is uncertain.

                  c.        By FY94, increased production of both vaccines will
            begin.

                      (1)        The Army indemnified the National Cancer
            Institute (NCI) for the production of anthrax. Production
            estimates should allow DoD to protect                   per year against
            anthrax. (NCI production rate estimated to be three million
            doses per year.)

                            (a) (U) This allows Michigan Department of Public
            Health (MDPH) to transfer its effort to produce botulinum toxoid.

uction effort of Porton,
            U.S. Army Medical Research Institute of Infectious Diseases and
            MDPH is expected to yield enough vaccine to protect                 @i4s
            against botulinum per year. (Production rate estima ed
            doses per year.)

                      (2)        Based on current projections, a vaccinated
            force of                                           for botulinum can
            be maintained by PY97. These projections are based on maximum


                                             UNCLASSIFIED
         CLASSIFIED BY: Multiple Sources
         DECLASSIFY ON: OADR

Document 15 f:/Week-36/BX003203/JOINT BIO WARFARE DEFENSE COMMITTEE TANK BRIEF/joint biological warfare defense committee tank :12179609290764
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = JOINT BIO WARFARE DEFENSE COMMITTEE TANK BRIEF
Folder Seq # = 248
Subject = JOINT BIOLOGICAL WARFARE DEFENSE COMMITTEE TANK
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 17-DEC-1996